PAPERS DISCUSSED BY DR VENOOK (HEPATOCELLULAR CARCINOMA)

Cheng A-L et al. Randomized phase III trial of sorafenib versus placebo in Asian patients with advanced hepatocellular carcinoma. Proc ASCO 2008;Abstract 4509.

Abou-Alfa GK et al. Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis? Proc ASCO 2008;Abstract 4518.

Raoul J-L et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to ECOG performance status: A subanalysis from the SHARP trial. Proc ASCO 2008;Abstract 4587.

Zhu AX et al. Sunitinib monotherapy in patients with advanced hepatocellular carcinoma (HCC): Insights from a multidisciplinary phase II study. Proc ASCO 2008;Abstract 4521.